- Home
- PRTC vs AII Comparison
PRTC vs AII Comparison
Compare PRTC & AII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTC
- AII
- Stock Information
- Founded
- PRTC 2015
- AII 2006
- Country
- PRTC United States
- AII United States
- Employees
- PRTC N/A
- AII N/A
- Industry
- PRTC Biotechnology: Pharmaceutical Preparations
- AII Property-Casualty Insurers
- Sector
- PRTC Health Care
- AII Finance
- Exchange
- PRTC Nasdaq
- AII Nasdaq
- Market Cap
- PRTC 388.6M
- AII 379.5M
- IPO Year
- PRTC N/A
- AII 2025
- Fundamental
- Price
- PRTC $15.39
- AII $20.45
- Analyst Decision
- PRTC Buy
- AII Buy
- Analyst Count
- PRTC 1
- AII 4
- Target Price
- PRTC $45.00
- AII $21.67
- AVG Volume (30 Days)
- PRTC 5.0K
- AII 86.6K
- Earning Date
- PRTC 08-28-2025
- AII 08-12-2025
- Dividend Yield
- PRTC N/A
- AII N/A
- EPS Growth
- PRTC N/A
- AII N/A
- EPS
- PRTC 0.20
- AII 3.87
- Revenue
- PRTC $6,391,000.00
- AII $260,047,000.00
- Revenue This Year
- PRTC N/A
- AII $25.82
- Revenue Next Year
- PRTC N/A
- AII $25.78
- P/E Ratio
- PRTC $7.29
- AII $5.24
- Revenue Growth
- PRTC 1265.60
- AII 1.73
- 52 Week Low
- PRTC $13.30
- AII $15.78
- 52 Week High
- PRTC $24.99
- AII $20.61
- Technical
- Relative Strength Index (RSI)
- PRTC 34.46
- AII N/A
- Support Level
- PRTC $15.75
- AII N/A
- Resistance Level
- PRTC $16.75
- AII N/A
- Average True Range (ATR)
- PRTC 0.62
- AII 0.00
- MACD
- PRTC -0.14
- AII 0.00
- Stochastic Oscillator
- PRTC 0.00
- AII 0.00
About PRTC PureTech Health plc
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
About AII American Integrity Insurance Group Inc. Common Stock
American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, South Carolina, and Georgia.